Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User & Region - Global Forecast to 2027
Updated on : March 29, 2023
The global protein expression market in terms of revenue was estimated to be worth $2.9 billion in 2022 and is poised to grow at a CAGR of 13.3% from 2022 to 2027.
The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Factors such as growth in the life science and biopharmaceutical industries, a rise in the focus on recombinant-based protein expression, and the availability of investment for protein-based research. However, the high cost of protein expression reagents and instruments is expected to restrain the growth of this market to a certain extent.
Attractive Opportunities in the Protein Expression Market
To know about the assumptions considered for the study, Request for Free Sample Report
Protein Expression Market Growth Dynamics
Drivers: Increasing demand for protein biologics
Most of the chronic diseases such as cancer, autoimmune diseases and other serious diseases are treated using biologics. These biologics include vaccines, blood and blood components, and recombinant therapeutic proteins. In 2021, the FDA approved 50 novel drugs. 14 out of these were biologics, all of which required protein expression as they were either of the following- monoclonal antibodies, Pegylated Protein, hormones and enzymes. In addition, several mAbs, such as tocilizumab, sotrovimab, and the co-administration of bamlanivimab and etesevimab, had received EUA for COVID19 treatment (mild to moderated) and evusheld (co-package of tixagevimab with cilgavimab) were authorized as a prophylactic for the prevention of the infection. Several of these drugs are likely to get drug approvals from the FDA by 2022. Thus, increasing demand for protein biologics is leading to an increase in the usage of protein expression products and services, which in turn is driving the growth of this market.
Opportunities: Emergence of microfluidics
Microfluidics is one of the most important and advanced techniques used in protein expression studies and research, with growing interest in the heterologous production of proteins such as antibodies, growth factors, nanobodies, and high-quality protein food ingredients. The demand for efficient production hosts is increasing. In a study conducted in 2021, Corynebacterium glutamicum was tested for improving protein production with the use of droplet-based microfluidic (DBM) high throughput screening. The results showed that DBM screening serves as a powerful development tool to improve cell factories for the production and secretion of heterologous proteins. Moreover, the Microfluidic antibody capture (MAC) chip is another novel technology that is used to measure the expression level of different proteins and their phosphorylation at the single-cell level. Advancements in microfluidics technology have provided robust solutions for the analysis and evaluation of tumorous and non-tumorous cells. Moreover, the innovative and advanced applications of microfluidics in protein expression research will help overcome challenges related to protein analysis; this technology is therefore expected to provide significant growth opportunities for market players during the forecast period.
Challenges: Undesired post-translational modifications and purification
Protein expression process leads to formation of crude proteins. These are further extracted and purified. Due to the intrinsic complexity of proteins in general, protein expression and purification are often challenging. Proteins are complex structures with folds. Therefore, certain sequences or structural features within a protein can impact the yield and stability of the protein products. For instance, the presence of transmembrane domains or GPI-anchor sequences often causes the association of target proteins with the plasma membrane, resulting in a compromised protein yield. However, the over-expression and accumulation of the target protein might cause unexpected physiological changes to the host cells, resulting in the production of misfolded proteins and protein degradation by the host proteases. These pose a challenge to the protein expression market growth.
Restraints: High cost of protein expression reagents and instruments
High quality bioactive proteins are produced at a large-scale using protein expression systems. Owing to their high quality and purity level, they are priced at a premium. Therefore, the overall production cost of bioactive proteins increases significantly due to the high cost of reagents. E. coli-based protein expression systems are not expensive; however, the large-scale production of proteins using an E.coli expression system can be expensive. Moreover, instruments based on protein expression systems are also expensive. This is a major factor restricting the adoption of protein expression systems and instruments in both industrial and research applications, especially in emerging countries.
The Mammalian expression system subsegment of the System segment dominated the Protein Expression Market in 2021
Based on the system type, the market is segmented into mammalian cell expression systems, prokaryotic expression systems, insect cell expression systems, yeast expression systems, cell-free expression systems, and algal-based expression systems. The mammalian cell expression systems segment accounted for the largest share of the global protein expression market in 2021. Owing to the low cost and ease of use of mammalian cell expression systems, they have the largest share of this market.
To know about the assumptions considered for the study, download the pdf brochure
North America was the largest regional market for Protein Expression Market in 2021.
North America accounted for the largest share of the global market. As a result of the growth in the biotechnology and pharmaceutical industries, the rising prevalence of chronic disorders, and an increase in protein-based therapeutics research investments in the region, North America holds the largest share.
The key players in the global protein expression market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), GenScript Biotech Corporation (US), Agilent Technologies Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Takara Bio Inc. (Japan), Bio-Rad Laboratories Inc. (US), Lonza Group AG (Switzerland), Promega Corporation (US), New England Biolabs (US), and Oxford Expression Technologies Ltd. (UK).
Protein Expression Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2022 |
$2.9 billion |
|
Estimated Value by 2027 |
$5.4 billion |
|
Growth Rate |
Poised to grow at a CAGR of 13.3% |
|
Largest Share Segments |
Mammalian expression system subsegment of the System segment |
|
Market Report Segmentation |
System Type, Product & Service, Application, End user, and Region |
|
Growth Drivers |
|
|
Growth Opportunities |
|
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
This report categorizes the Protein Expression market into the following segments and sub-segments:
By System Type
- Mammalian cell expression systems
- Prokaryotic expression systems
- Insect cell expression systems
- Yeast expression systems
- Cell-free expression systems
- Algal-based expression systems
By Application
- Therapeutic
- Research
- Industrial
By End user
- Pharmaceutical and Biotechnology companies
- Contract Research Organizations and Contract Development and Manufacturing Organizations (CROs and CDMOs)
- Academic Research Institutes
- Other End Users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
-
Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- Rest of Asia Pacific (RoAPAC)
- Rest of the World (RoW)
- Latin America
- Middle East and Africa
Recent Developments:
- In June 2021, Thermo Fisher Scientific Inc. (US) and Advanced Electrophoresis Solutions Ltd. (AES) (Canada) signed an agreement to combine essential protein separation techniques with mass spectrometry (MS) to advance therapeutic protein development through streamlined characterization.
- In June 2020, Lonza Group AG (Switzerland) launched GSv9, a chemically defined media and feeds platform specifically developed to enhance the performance of the GS Gene Expression System for optimized recombinant protein production.
Frequently Asked Questions (FAQ):
Who are the key players in the Protein Expression market?
The key players in the global protein expression market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), GenScript Biotech Corporation (US), Agilent Technologies Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Takara Bio Inc. (Japan), Bio-Rad Laboratories Inc. (US), Lonza Group AG (Switzerland), Promega Corporation (US), New England Biolabs (US), and Oxford Expression Technologies Ltd. (UK).
Which system type dominates the Protein Expression market?
In 2021, Mammalian expression system. Factors such as low cost and ease of use of mammalian cell expression systems are driving the growth of this segment.
Which application segment of the Protein Expression market is expected to witness the highest growth?
Research applications segment is expected to witness the highest growth during the forecast period. Increasing research in the protein expression field and increasing government support are factors driving the growth of the research applications market.
What is the market size for the Protein Expression market?
The global 3D Bioprinting market is estimated to grow from USD 2.9 billion in 2022 to reach USD 5.4 billion by 2027, at a CAGR of 13.3% during the forecast period.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 43)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 47)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2021
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 MARKET (SUPPLY SIDE): CAGR PROJECTIONS
FIGURE 7 MARKET (DEMAND SIDE): GROWTH ANALYSIS OF FACTORS
2.3.1 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.4.1 COVID-19-SPECIFIC ASSUMPTIONS
2.5 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 58)
FIGURE 9 MARKET, BY SYSTEM TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 12 MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MARKET
4 PREMIUM INSIGHTS (Page No. - 62)
4.1 PROTEIN EXPRESSION MARKET OVERVIEW
FIGURE 14 INCREASING DEMAND FOR PROTEIN BIOLOGICS TO DRIVE MARKET
4.2 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021)
FIGURE 15 US TO COMMAND LARGEST SHARE OF NORTH AMERICAN MARKET IN 2021
4.3 MARKET SHARE, BY SYSTEM TYPE, 2022 VS. 2027
FIGURE 16 MAMMALIAN CELL EXPRESSION SYSTEM TO DOMINATE MARKET IN 2027
4.4 MARKET SHARE, BY END USER, 2022
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE LARGEST END USERS
4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 66)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing demand for protein biologics
TABLE 1 BIOLOGICS AND CELL LINES USED
TABLE 2 BIOLOGICS APPROVED BY FDA IN 2021
TABLE 3 PROTEINS SYNTHESIZED BY PROTEIN EXPRESSION AND GENETIC ENGINEERING
FIGURE 20 DIABETES CASES, BY REGION, 2021 VS. 2045 (MILLION)
TABLE 4 GLOBAL INCIDENCE OF CANCER, BY TYPE (2020)
5.2.1.2 Increasing R&D in pharmaceutical and biopharmaceutical industries
5.2.1.3 Growing adoption of recombinant-based protein expression
5.2.1.4 Availability of funding for protein-based research
TABLE 5 GOVERNMENT FUNDING FOR PROTEIN-BASED RESEARCH (2017–2022)
5.2.2 RESTRAINTS
5.2.2.1 High cost of protein expression reagents and instruments
TABLE 6 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000 L IN DEVELOPED AND DEVELOPING COUNTRIES (2020)
5.2.2.2 Increasing consolidation and high barriers for new entrants
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of microfluidics
5.2.3.2 Emerging economies offering significant growth potential
5.2.4 CHALLENGE
5.2.4.1 Undesired post-translational modifications and purification
5.3 RANGES/SCENARIOS
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF MARKET
FIGURE 22 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 PRICING ANALYSIS
5.5 TECHNOLOGY ANALYSIS
TABLE 7 ADVANTAGES AND CHALLENGES OF RECOMBINANT PROTEIN EXPRESSION SYSTEMS
5.6 PATENT ANALYSIS
FIGURE 23 PATENT APPLICATIONS FOR MARKET, JANUARY 2011–MAY 2022
TABLE 8 INDICATIVE PATENT IN MARKET
5.7 VALUE CHAIN ANALYSIS
FIGURE 24 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASE TO CONTRIBUTE MAXIMUM VALUE
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 25 MARKET: SUPPLY CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS
TABLE 9 SUPPLY CHAIN ECOSYSTEM
5.10 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 10 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 15 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF PROTEIN EXPRESSION PRODUCTS AND SERVICES
5.13.2 BUYING CRITERIA FOR PROTEIN EXPRESSION PRODUCTS
FIGURE 27 KEY BUYING CRITERIA FOR END USERS
6 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE (Page No. - 89)
6.1 INTRODUCTION
TABLE 16 MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
6.2 MAMMALIAN CELL EXPRESSION SYSTEMS
TABLE 17 MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 18 NORTH AMERICA: MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 19 EUROPE: MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 20 ASIA PACIFIC: MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 21 REST OF THE WORLD: MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 22 MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.1 CHINESE HAMSTER OVARY CELL SYSTEMS (CHO CELL SYSTEMS)
6.2.1.1 Chinese hamster ovary cell systems to dominate market
TABLE 23 MARKET FOR CHO CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 24 NORTH AMERICA: MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 25 EUROPE: MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 26 ASIA PACIFIC: MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 27 REST OF THE WORLD: MARKET FOR CHO CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.2.2 HUMAN EMBRYONIC KIDNEY CELL SYSTEMS (HEK 293 CELL SYSTEMS)
6.2.2.1 Increasing use of HEK 293 cells for producing biologics to boost market
TABLE 28 MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 29 NORTH AMERICA: MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 30 EUROPE: MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 31 ASIA PACIFIC: MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 32 REST OF THE WORLD: MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.2.3 OTHER MAMMALIAN CELL SYSTEMS
TABLE 33 MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 34 NORTH AMERICA: MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 EUROPE: MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 36 ASIA PACIFIC: MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 37 REST OF THE WORLD: MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.3 PROKARYOTIC EXPRESSION SYSTEMS
TABLE 38 MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 39 NORTH AMERICA: MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 40 EUROPE: MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 41 ASIA PACIFIC: MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 42 REST OF THE WORLD: MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 43 PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.3.1 ESCHERICHIA COLI SYSTEMS
6.3.1.1 Increasing use of E. coli systems for commercial protein production to fuel market
TABLE 44 MARKET FOR E. COLI SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 46 EUROPE: MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 47 ASIA PACIFIC: MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 48 REST OF THE WORLD: MARKET FOR E. COLI SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.3.2 OTHER PROKARYOTIC EXPRESSION SYSTEMS
TABLE 49 MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 50 NORTH AMERICA: MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 EUROPE: MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 52 ASIA PACIFIC: MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 53 REST OF THE WORLD: MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.4 INSECT CELL EXPRESSION SYSTEMS
TABLE 54 MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 55 NORTH AMERICA: MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 56 EUROPE: MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 57 ASIA PACIFIC: MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 58 REST OF THE WORLD: MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 59 INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.4.1 BACULOVIRUS SYSTEMS
6.4.1.1 Baculovirus systems to show high yield and expression levels for intracellular proteins
TABLE 60 MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 61 NORTH AMERICA: MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 63 ASIA PACIFIC: MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 64 REST OF THE WORLD: MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.4.2 OTHER INSECT CELL SYSTEMS
TABLE 65 MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 66 NORTH AMERICA: MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 67 EUROPE: MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 68 ASIA PACIFIC: MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 69 REST OF THE WORLD: MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.5 YEAST EXPRESSION SYSTEMS
TABLE 70 MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 71 NORTH AMERICA: MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 72 EUROPE: MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 73 ASIA PACIFIC: MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 74 REST OF THE WORLD: MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 75 YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.5.1 PICHIA SYSTEMS
6.5.1.1 Pichia systems to hold largest market share
TABLE 76 MARKET FOR PICHIA SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 77 NORTH AMERICA: MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 78 EUROPE: MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 79 ASIA PACIFIC: MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 REST OF THE WORLD: MARKET FOR PICHIA SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.5.2 SACCHAROMYCES SYSTEMS
6.5.2.1 Saccharomyces systems to channelize direction of foreign proteins into secretory pathways using various signals
TABLE 81 MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 82 NORTH AMERICA: MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 83 EUROPE: MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 84 ASIA PACIFIC: MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 85 REST OF THE WORLD: MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.5.3 OTHER YEAST EXPRESSION SYSTEMS
TABLE 86 MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 87 NORTH AMERICA: MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 88 EUROPE: MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 89 ASIA PACIFIC: MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 90 REST OF THE WORLD: MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.6 CELL-FREE EXPRESSION SYSTEMS
6.6.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS TO SUPPORT MARKET
TABLE 91 MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 92 NORTH AMERICA: MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 93 EUROPE: MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 94 ASIA PACIFIC: MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 95 REST OF THE WORLD: MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
6.7 ALGAL-BASED EXPRESSION SYSTEMS
6.7.1 GROWTH IN VACCINES MARKET TO SUPPORT SEGMENT
TABLE 96 MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 97 NORTH AMERICA: MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 98 EUROPE: MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 99 ASIA PACIFIC: MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 100 REST OF THE WORLD: MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION)
7 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE (Page No. - 129)
7.1 INTRODUCTION
TABLE 101 MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
7.2 REAGENTS
7.2.1 REAGENTS TO DOMINATE MARKET DURING FORECAST PERIOD
TABLE 102 PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 103 NORTH AMERICA: MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 104 EUROPE: MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 105 ASIA PACIFIC: MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 106 REST OF THE WORLD: MARKET FOR REAGENTS, BY REGION, 2020–2027 (USD MILLION)
7.3 EXPRESSION VECTORS
7.3.1 EXPRESSION VECTORS TO BE INDISPENSABLE FOR PROTEIN EXPRESSION
TABLE 107 MARKET FOR EXPRESSION VECTORS, BY REGION, 2020–2027 (USD MILLION)
TABLE 108 NORTH AMERICA: MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 109 EUROPE: MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 110 ASIA PACIFIC: MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 111 REST OF THE WORLD: MARKET FOR EXPRESSION VECTORS, BY REGION, 2020–2027 (USD MILLION)
7.4 COMPETENT CELLS
7.4.1 INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO DRIVE MARKET
TABLE 112 MARKET FOR COMPETENT CELLS, BY REGION, 2020–2027 (USD MILLION)
TABLE 113 NORTH AMERICA: MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 114 EUROPE: MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 115 ASIA PACIFIC: MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 116 REST OF THE WORLD: MARKET FOR COMPETENT CELLS, BY REGION, 2020–2027 (USD MILLION)
7.5 INSTRUMENTS
7.5.1 INSTRUMENTS TO EFFICIENTLY TRANSFER GENETIC MATERIALS INTO HOST CELLS
TABLE 117 MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION)
TABLE 118 NORTH AMERICA: MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 119 EUROPE: MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 120 ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 121 REST OF THE WORLD: MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION)
7.6 SERVICES
7.6.1 RISING DEMAND FOR CUSTOMIZED PROTEINS TO PROPEL MARKET
TABLE 122 MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION)
TABLE 123 NORTH AMERICA: MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 124 EUROPE: MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 125 ASIA PACIFIC: MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 126 REST OF THE WORLD: MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION)
8 PROTEIN EXPRESSION MARKET, BY APPLICATION (Page No. - 143)
8.1 INTRODUCTION
TABLE 127 MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 THERAPEUTIC APPLICATIONS
8.2.1 THERAPEUTIC PROTEINS TO TREAT PATHOLOGICAL CONDITIONS
TABLE 128 THERAPEUTIC PROTEINS AND INDICATION
TABLE 129 MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 130 NORTH AMERICA: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 131 EUROPE: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 132 ASIA PACIFIC: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 133 REST OF THE WORLD: THERAPEUTIC APPLICATIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
8.3 RESEARCH APPLICATIONS
8.3.1 INCREASING INVESTMENTS IN RESEARCH ACTIVITIES TO DRIVE SEGMENT
TABLE 134 MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 135 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 136 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 137 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 138 REST OF THE WORLD: MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8.4 INDUSTRIAL APPLICATIONS
8.4.1 GROWTH IN EXPRESSION SYSTEMS FOR INDUSTRIAL ENZYMES PRODUCTION TO SUPPORT SEGMENT
TABLE 139 MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 140 NORTH AMERICA: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 141 EUROPE: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 142 ASIA PACIFIC: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 143 REST OF THE WORLD: MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
9 PROTEIN EXPRESSION MARKET, BY END USER (Page No. - 153)
9.1 INTRODUCTION
TABLE 144 MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE END USERS MARKET
TABLE 145 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 146 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 147 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 148 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 149 REST OF THE WORLD: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
9.3 ACADEMIC RESEARCH INSTITUTES
9.3.1 INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET
TABLE 150 MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
TABLE 151 NORTH AMERICA: MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 152 EUROPE: MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 153 ASIA PACIFIC: MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 154 REST OF THE WORLD: MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
9.4 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS & CDMOS)
9.4.1 CLINICAL TRIALS, OUTSOURCING, AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING TO BOOST MARKET
TABLE 155 MARKET FOR CROS & CDMOS, BY REGION, 2020–2027 (USD MILLION)
TABLE 156 NORTH AMERICA: MARKET FOR CROS & CDMOS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 157 EUROPE: MARKET FOR CROS & CDMOS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 158 ASIA PACIFIC: MARKET FOR CROS & CDMOS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 159 REST OF THE WORLD: MARKET FOR CROS & CDMOS, BY REGION, 2020–2027 (USD MILLION)
9.5 OTHER END USERS
TABLE 160 MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
TABLE 161 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 162 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 163 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 164 ROW: MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
10 PROTEIN EXPRESSION MARKET, BY REGION (Page No. - 164)
10.1 INTRODUCTION
TABLE 165 MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT
TABLE 166 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 167 NORTH AMERICA: MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 168 NORTH AMERICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 NORTH AMERICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 NORTH AMERICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 NORTH AMERICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 173 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 174 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate global protein expression market
TABLE 175 US: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 176 US: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 US: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 US: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 US: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 US: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 181 US: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 182 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Government funding for research and innovation to support market
TABLE 183 CANADA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 184 CANADA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 CANADA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 186 CANADA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 187 CANADA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 188 CANADA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 189 CANADA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 190 CANADA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 191 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 192 EUROPE: MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 193 EUROPE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 EUROPE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 EUROPE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 EUROPE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 197 EUROPE: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 198 EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 199 EUROPE: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate market share in Europe
TABLE 200 GERMANY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 201 GERMANY: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 GERMANY: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 203 GERMANY: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 GERMANY: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 GERMANY: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 206 GERMANY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 207 GERMANY: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Surge in number of chronic diseases to boost market
TABLE 208 UK: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 209 UK: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 210 UK: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 UK: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 UK: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 213 UK: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 214 UK: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 215 UK: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing biotech R&D to drive market
TABLE 216 FRANCE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 217 FRANCE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 FRANCE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 219 FRANCE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 220 FRANCE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 221 FRANCE: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 222 FRANCE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 223 FRANCE: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increase in life sciences research projects to fuel market
TABLE 224 ITALY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 225 ITALY: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 226 ITALY: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 227 ITALY: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 228 ITALY: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 229 ITALY: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 230 ITALY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 231 ITALY: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Network of research centers, universities, and hospitals to propel market
TABLE 232 SPAIN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 233 SPAIN: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 234 SPAIN: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 235 SPAIN: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 236 SPAIN: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 237 SPAIN: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 238 SPAIN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 239 SPAIN: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 240 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 241 REST OF EUROPE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 242 REST OF EUROPE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 243 REST OF EUROPE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 244 REST OF EUROPE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 245 REST OF EUROPE: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 246 REST OF EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 247 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT
TABLE 248 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 249 ASIA PACIFIC: MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 250 ASIA PACIFIC: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 251 ASIA PACIFIC: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 252 ASIA PACIFIC: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 253 ASIA PACIFIC: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 254 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 255 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 256 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Growth in R&D to enhance technological capabilities
TABLE 257 CHINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 258 CHINA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 259 CHINA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 260 CHINA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 261 CHINA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 262 CHINA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 263 CHINA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 264 CHINA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Increasing protein-based research to stimulate market
TABLE 265 JAPAN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 266 JAPAN: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 267 JAPAN: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 268 JAPAN: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 269 JAPAN: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 270 JAPAN: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 271 JAPAN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 272 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing government support to drive market
TABLE 273 INDIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 274 INDIA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 275 INDIA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 276 INDIA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 277 INDIA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 278 INDIA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 279 INDIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 280 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Increasing focus of healthcare system on precision medicine to fuel market
TABLE 281 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 282 AUSTRALIA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 283 AUSTRALIA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 284 AUSTRALIA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 285 AUSTRALIA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 286 AUSTRALIA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 287 AUSTRALIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 288 AUSTRALIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 289 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 290 REST OF ASIA PACIFIC: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 291 REST OF ASIA PACIFIC: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 292 REST OF ASIA PACIFIC: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 293 REST OF ASIA PACIFIC: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 294 REST OF ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 295 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 296 REST OF ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 297 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 298 REST OF THE WORLD: MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 299 REST OF THE WORLD: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 300 REST OF THE WORLD: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 301 REST OF THE WORLD: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 302 REST OF THE WORLD: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 303 REST OF THE WORLD: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 304 REST OF THE WORLD: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 305 REST OF THE WORLD: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.1 LATIN AMERICA
10.5.1.1 Growth in biopharmaceutical industry to support market
TABLE 306 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 307 LATIN AMERICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 308 LATIN AMERICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 309 LATIN AMERICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 310 LATIN AMERICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 311 LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 312 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 313 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.2 MIDDLE EAST & AFRICA
10.5.2.1 Increasing government investments in healthcare sector and growing pharmaceuticals industry to support market
TABLE 314 MIDDLE EAST & AFRICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
TABLE 315 MIDDLE EAST & AFRICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 316 MIDDLE EAST & AFRICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 317 MIDDLE EAST & AFRICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 318 MIDDLE EAST & AFRICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 319 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 320 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 321 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 244)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.3 MARKET SHARE ANALYSIS
TABLE 322 PROTEIN EXPRESSION MARKET: DEGREE OF COMPETITION
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 33 MARKET: COMPANY EVALUATION QUADRANT, 2021
11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 34 MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
11.7 COMPANY FOOTPRINT ANALYSIS
11.7.1 PRODUCT FOOTPRINT OF COMPANIES
TABLE 323 PRODUCT AND SERVICE FOOTPRINT OF COMPANIES IN PROTEIN EXPRESSION MARKET (2021)
11.8 REGIONAL FOOTPRINT OF COMPANIES
TABLE 324 REGIONAL FOOTPRINT OF COMPANIES IN MARKET (2021)
11.9 COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS
TABLE 325 PROTEIN EXPRESSION MARKET: DETAILED LIST OF KEY START-UPS/SME PLAYERS
11.10 COMPETITIVE SCENARIO
TABLE 326 KEY PRODUCT/ SERVICE LAUNCHES
TABLE 327 KEY DEALS
TABLE 328 EXPANSION
12 COMPANY PROFILES (Page No. - 257)
(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
12.1 KEY PLAYERS
12.1.1 THERMO FISHER SCIENTIFIC, INC.
TABLE 329 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
FIGURE 35 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
12.1.2 MERCK KGAA
TABLE 330 MERCK KGAA: COMPANY OVERVIEW
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT
12.1.3 GENSCRIPT BIOTECH CORPORATION
TABLE 331 GENSCRIPT BIOTECH CORPORATION: BUSINESS OVERVIEW
FIGURE 37 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2021)
12.1.4 AGILENT TECHNOLOGIES INC.
TABLE 332 AGILENT TECHNOLOGIES INC.: COMPANY OVERVIEW
FIGURE 38 AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT (2021)
12.1.5 TAKARA BIO, INC.
TABLE 333 TAKARA BIO, INC.: COMPANY OVERVIEW
FIGURE 39 TAKARA BIO, INC.: COMPANY SNAPSHOT (2021)
12.1.6 BIO-RAD LABORATORIES, INC.
TABLE 334 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
FIGURE 40 TAKARA BIO, INC.: COMPANY SNAPSHOT (2021)
12.1.7 QIAGEN N.V.
TABLE 335 QIAGEN N.V.: COMPANY OVERVIEW
FIGURE 41 QIAGEN N.V..: COMPANY SNAPSHOT (2021)
12.1.8 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
TABLE 336 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY OVERVIEW
FIGURE 42 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2021)
12.1.9 DANAHER CORPORATION
TABLE 337 DANAHER CORPORATION: COMPANY OVERVIEW
FIGURE 43 DANAHER CORPORATION: COMPANY SNAPSHOT
12.1.10 SARTORIUS AG
TABLE 338 SARTORIUS AG: COMPANY OVERVIEW
FIGURE 44 SARTORIUS AG: COMPANY SNAPSHOT
12.1.11 CORNING INCORPORATED
TABLE 339 CORNING INCORPORATED: COMPANY OVERVIEW
FIGURE 45 CORNING INCORPORATED: COMPANY SNAPSHOT
12.1.12 FUJIFILM IRVINE SCIENTIFIC, INC. (ACQUIRED BY FUJIFILM HOLDINGS CORPORATION)
TABLE 340 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 46 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
12.1.13 LONZA GROUP AG
TABLE 341 LONZA GROUP AG: COMPANY OVERVIEW
FIGURE 47 LONZA GROUP AG: COMPANY SNAPSHOT (2021)
12.1.14 BIONEER CORPORATION
TABLE 342 BIONEER CORPORATION: COMPANY OVERVIEW
12.1.15 PROMEGA CORPORATION
TABLE 343 PROMEGA CORPORATION: COMPANY OVERVIEW
12.1.16 OXFORD EXPRESSION TECHNOLOGIES LTD.
TABLE 344 OXFORD EXPRESSION TECHNOLOGIES LTD.: COMPANY OVERVIEW
12.1.17 PROTEOGENIX
TABLE 345 PROTEOGENIX: COMPANY OVERVIEW
12.1.18 ABEOMICS INC.
TABLE 346 ABEOMICS INC.: COMPANY OVERVIEW
12.1.19 NEW ENGLAND BIOLABS, INC.
TABLE 347 NEW ENGLAND BIOLABS, INC.: COMPANY OVERVIEW
12.2 OTHER PLAYERS
12.2.1 PROMAB BIOTECHNOLOGIES
12.2.2 SINO BIOLOGICAL, INC.
12.2.3 JENA BIOSCIENCE
12.2.4 LIFESENSORS, INC.
12.2.5 LEADING BIOLOGY, INC.
12.2.6 PEAK PROTEINS
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 319)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information to analyze the global protein expression market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary sources referred to for this research study included corporate filings (such as annual reports, SEC filings, and financial statements), research journals, press releases, and trade, business, and professional associations. These secondary sources were used to identify and collect useful information for this extensive, technical, and commercial study of the market. Secondary research was mainly used to obtain key information about the industry’s total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, market trends, and key developments by both public and private organizations in the market.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CDMOs and CROs, academic and research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 60% and 40% of the primary interviews were conducted with supply-side and demand-side participants. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the protein expression market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive primary and secondary research.
- The revenues generated from the protein expression business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Report Objectives
- To define, describe, and forecast the protein expression market on the basis of system type, product & service, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth, such as drivers, restraints, opportunities, and challenges
- To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the revenue of the market segments with respect to five main regions, namely, North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, and the Rest of Asia Pacific), Rest of the World (Latin America, and the Middle East & Africa).
- To profile the key market players and comprehensively analyze their market shares and core competencies2
- To track and analyze competitive developments such as product launches, agreements, partnerships, acquisitions, business expansions, and research & development activities in the protein expression market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Protein Processing Market Share
The global protein processing market size was estimated at USD 2.9 billion in 2022 and is expected to reach USD 5.4 billion in the coming years, growing at a CAGR of 13.3%.
Below are the top 10 growth use-cases in the protein processing market
- Food and Beverage Industry: The food and beverage industry is the largest end-user of protein processing products, accounting for the majority of the market share. Proteins are used in a wide range of food and beverage products, including meat products, dairy products, and plant-based alternatives.
- Animal Feed Industry: The animal feed industry is another significant end-user of protein processing products. Proteins are added to animal feed to enhance the nutritional value and promote animal health and growth.
- Pharmaceutical Industry: The pharmaceutical industry is a growing market for protein processing products. Proteins are used as therapeutics, vaccines, and diagnostic agents in the treatment and diagnosis of various diseases.
- Personal Care Industry: The personal care industry is another growing market for protein processing products. Proteins are used in skincare, haircare, and other personal care products to improve their efficacy and provide various benefits, such as moisturizing, anti-aging, and strengthening.
- Agriculture Industry: The agriculture industry is a growing market for protein processing products. Proteins are used in the production of fertilizers and other agricultural inputs to enhance plant growth and productivity.
- Textile Industry: The textile industry is another growing market for protein processing products. Proteins are used in the production of textile fibers, such as silk and wool, to improve their strength, durability, and other properties.
- Biotechnology Industry: The biotechnology industry is a significant market for protein processing products. Proteins are used in research and development, drug discovery, and other applications in the biotechnology industry.
- Environmental Industry: The environmental industry is a growing market for protein processing products. Proteins are used in various environmental applications, such as wastewater treatment, bioremediation, and soil stabilization.
- Cosmetics Industry: The cosmetics industry is a growing market for protein processing products. Proteins are used in the production of various cosmetic products, such as makeup and skincare, to enhance their efficacy and provide various benefits.
- Nutraceutical Industry: The nutraceutical industry is a growing market for protein processing products. Proteins are used in the production of various nutraceutical products, such as dietary supplements and functional foods, to enhance their nutritional value and provide various health benefits.
Top 10 companies in Protein Processing Market by Region
North America:
- Archer Daniels Midland Company
- Cargill, Incorporated
- Tyson Foods, Inc.
- Kerry Group
- Ingredion Incorporated
- Ajinomoto Co., Inc.
- Tate & Lyle PLC
- Darling Ingredients Inc.
- Bunge Limited
- DuPont de Nemours, Inc.
Europe:
- Chr. Hansen Holding A/S
- Royal DSM N.V.
- Novozymes A/S
- Kerry Group
- Tate & Lyle PLC
- Corbion N.V.
- Ingredion Incorporated
- Archer Daniels Midland Company
- Cargill, Incorporated
- Givaudan SA
Asia-Pacific:
- Ajinomoto Co., Inc.
- Kerry Group
- Archer Daniels Midland Company
- Cargill, Incorporated
- Tate & Lyle PLC
- Koninklijke DSM N.V.
- The Nisshin OilliO Group, Ltd.
- CP Kelco
- Ingredion Incorporated
- AVEBE U.A.
Latin America:
- Cargill, Incorporated
- Kerry Group
- Archer Daniels Midland Company
- Ingredion Incorporated
- Bunge Limited
- Tate & Lyle PLC
- DuPont de Nemours, Inc.
- Omega Protein Corporation
- FMC Corporation
- Corbion N.V.
Middle East and Africa:
- Cargill, Incorporated
- Archer Daniels Midland Company
- Ingredion Incorporated
- Kerry Group
- Tate & Lyle PLC
- The Scoular Company
- DowDuPont Inc.
- Roquette Frères
- AECI Limited
- AGRANA Beteiligungs-AG
Niche Threats for Protein Processing Market in Europe and North America
Europe:
- Stringent regulations: European countries have strict regulations on food safety, animal welfare, and environmental sustainability, which could increase compliance costs and limit market opportunities.
- Brexit: The UK's exit from the European Union could result in regulatory divergence and disruption to supply chains, which could affect trade and investment in the protein processing sector.
- Competition from plant-based proteins: The growing popularity of vegetarian and vegan diets has led to increased demand for plant-based proteins, which could compete with animal-based proteins and reduce market share for the protein processing industry.
North America:
- Health and safety concerns: The protein processing industry has faced criticism over issues such as antibiotic use, animal welfare, and worker safety, which could lead to negative publicity and consumer backlash.
- Trade policies: Changes in trade policies, such as tariffs and quotas, could affect export markets for the protein processing industry, particularly with respect to China and other major buyers.
- Price volatility: Fluctuations in feed costs, energy prices, and other input costs could affect profitability and competitiveness for the protein processing industry, particularly in the face of increasing competition from global producers.
Impact of Recession on Protein Processing Market
The impact of a recession on the protein processing market can be significant, as it can lead to reduced consumer spending, decreased demand for animal products, and increased competition from cheaper alternatives.
Some hypothetic examples of how a recession could impact the protein processing business:
- Reduced consumer spending: During a recession, consumers may cut back on spending, particularly on discretionary items such as high-end meat and protein products. This could lead to decreased demand for premium animal proteins and higher-priced processed meat products.
- Increased competition from plant-based alternatives: As consumers look for cheaper alternatives to animal protein, plant-based alternatives such as tofu, tempeh, and seitan may become more popular, leading to increased competition for the protein processing industry.
- Supply chain disruptions: A recession could also lead to disruptions in the supply chain, as suppliers struggle with lower demand and reduced cash flow. This could lead to shortages of raw materials or higher prices for protein processors.
- Reduced investment in research and development: During a recession, companies may cut back on spending for research and development, which could slow innovation in the protein processing industry and reduce the introduction of new products.
- Shift in consumer preferences: A recession may also cause consumers to shift their preferences towards cheaper, less processed, or more sustainable protein sources, which could impact the market share and profitability of certain segments of the protein processing industry.
Overall, the impact of a recession on the protein processing market will depend on a range of factors, including the severity and duration of the economic downturn, consumer behavior, and the ability of companies to adapt to changing market conditions.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Generating Response ...
Growth opportunities and latent adjacency in Protein Expression Market